Point-of-Care Testing– tag –
-
Wissen Research Forecasts In-Vitro Diagnostics Market to Reach $170.1 Billion by 2031, Driven by 7.7% CAGR
PR Newswire Global Overview This article provides an overview of a market research report published by Wissen Research on the global In-Vitro Diagnostics (IVD) market. The report projects the global IVD market to reach $170.1 billion by ... -
CAP Emphasizes Crucial Role of Rapid POCT in Combating STIs, Driving Efficient Care
The National Law Review USA Overview The College of American Pathologists (CAP) has published an article highlighting the significant benefits of point-of-care testing (POCT) for sexually transmitted infections (STIs), emphasizing its ro... -
Roche Diagnostics Bolsters Comprehensive Point-of-Care Testing Portfolio for Diverse Clinical Settings
Roche Diagnostics USA Overview Roche Diagnostics is expanding its robust portfolio of point-of-care (POC) diagnostic solutions, encompassing devices, platforms, digital products, and services. These integrated solutions aim to deliver ra... -
Twisted Light Unlocks Faster, Ultra-Sensitive Disease Detection from Minute Samples
ARTIC Australia Overview Adelaide University has pioneered a groundbreaking 'twisted light' technology, promising significantly faster and more sensitive medical diagnostics, particularly with minuscule sample volumes. This innovation, l... -
Systematic Review Finds POCT Reduces Emergency Department Treatment Decision Time by 39.5% and Length of Stay by 29.2%
ResearchGate International Overview A systematic review published on ResearchGate on September 9, 2026, reveals that implementing Point-of-Care Testing (POCT) in emergency departments (EDs) significantly reduces laboratory turnaround tim... -
New Microwave Metamaterial Biosensor Achieves 600 MHz/RIU Sensitivity for Label-Free Blood and Hemoglobin Analysis
[Article, likely a news/research outlet] India Overview A newly developed microwave metamaterial biosensor, employing a compact microstrip architecture, enables label-free blood and hemoglobin analysis. The sensor achieves a maximum simu... -
Graphene Field-Effect Transistor Biosensors Advance Clinical Applications: Enabling Label-Free, High-Sensitivity Disease Biomarker Detection
PMC Switzerland Overview Graphene Field-Effect Transistor (GFET) biosensors are emerging as a promising platform for early disease diagnosis due to their high sensitivity, label-free detection, and compatibility with point-of-care testin... -
POCT Innovations Accelerate at MEDICA 2026: Biosensors, Imaging AI, and Lab-on-a-Chip Drive Precision Medicine
MEDICA Germany Overview MEDICA 2026 highlights significant advancements in Point-of-Care Testing (POCT), accelerating on-site diagnostics for rapid clinical decision-making. Progress in biosensors, imaging AI, biomarkers, and lab-on-a-ch... -
Next-Generation Electrochemical Biosensors Transform Clinical Diagnostics: Driving POCT and Personalized Medicine through Portability and AI Integration
Taylor & Francis Online Unknown Overview Advances in electrochemical biosensing are revolutionizing clinical and biochemical diagnostics, enabling rapid and highly sensitive detection of biomarkers for infectious diseases, metabolic diso... -
Lab-on-a-Chip & Microfluidics World Congress 2026 to Focus on POCT, Rapid Diagnostics, and Organ-on-a-Chip Technologies
SelectBIO Conferences Unknown Overview The SelectBIO Lab-on-a-Chip and Microfluidics World Congress 2026, scheduled for October 27-28, has been announced. This conference will specifically focus on Point-of-Care Testing (POCT), rapid dia...
